feed,title,long_url,short_url
SSRN,Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine vs. Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: Survival Trial Using Cyto kine Inhibitors),https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4095747,
